1. A new synergistic pharmaceutical composition for the preparation of a topical composition for the prevention and treatment of wounds, burn wounds, skin grafts, pressure sores and diabetic foot ulcers, containing mitogenic protein, one or more bactericidal agents and one or more bacteriostatic agents, and these topical compositions also contain one or more other ingredients. 2. The new synergistic pharmaceutical composition for producing a topical composition according to claim 1, wherein said mitogenic protein is one or more growth factors selected from the group consisting of recombinant human epidermal growth factor (rh-EGF) derived from platelets of growth factor AA and / or BB (rh-PDGF-AA and / or BB) or any other growth factor. 3. A new synergistic pharmaceutical composition for preparing a topical composition according to claim 1, wherein said bactericidal and bacteriostatic agents are selected from the group consisting of bacitracin, silver sulfadiazine (SSD), nitrofurazone, chlorhexidine gluconate (CHG), polymyxin B sulfate, neomycin, povidone iodine , mafenide, nitrofurazone and gentamicin. 4. A new synergistic pharmaceutical composition for preparing a topical composition according to claim 1 or 2, wherein said mitogenic protein is a recombinant human epidermal growth factor (rh-EGF). A new synergistic pharmaceutical composition for producing a topical composition according to claim 1 or 2, wherein the concentration of said mitogenic protein is from 1 μg / g to 15 μg / g w / w. A new synergistic pharmaceutical composition for producing a topical composition according to claim 1 or 3, where the concentration is indicated�1. Новая синергическая фармацевтическая композиция для получения топического состава для профилактики и лечения ран, ожоговых ран, кожных трансплантатов, пролежней и диабетических язв стоп, содержащая митогенный белок, одно или более бактерицидных средств и один или более бактериостатических средств, причем указанные топические составы т
